DNA vaccines for the prophylaxis and modulation of HSV infections

Bibliography

• CAPPEL R: Comparison of the humoral and cellular im-mune responses after immunization with live, UV in-activated Herpes Simplex Virus and a subunit vaccine and efficacy of these immunizations. Arch. Virol. (1976) 52:29–35.
   PubMed Web of Science ®Google Scholar
• STANBERRY LR, BERNSTEIN DI, BURKE RL eta].: Vaccina-tion with recombinant Herpes Simplex Virus glyco-proteins: protection against initial and recurrent genital herpes. J Infect. Dis. (1987) 155:914–920.
   Google Scholar
• MEIGNIER B, LONGNECKER R, ROIZMAN B: In vivo be-haviour of genetically engineered Herpes Simplex Vi-ruses R7017 and R7020: construction and evaluation in rodents. j Infect. Dis. (1988) 158:602–614.
   PubMed Web of Science ®Google Scholar
• MORRISON LA, KNIPE DM: Immunization with replica-tion defective mutants of Herpes Simplex Virus type 1: sites of immune intervention in pathogenesis of chal-lenge virus infection. J. Viro/. (1994) 68:689–696.
   PubMed Web of Science ®Google Scholar
• FARRELL HE, MCLEAN CS, HARLEY C eta].: Vaccine po-tential of a Herpes Simplex Virus type-1 mutant with an essential glycoprotein deleted. j Virof (1994) 68:927–932.
   Google Scholar
• SKINNER GRB, FINK CG, COWAN M eta].: Follow up re-port on 50 subjects vaccinated against herpes genitalis with skinner vaccine. Med. Microbiol. Immunol. (1987) 176:161–167.
   Google Scholar
• STANBERRY LR: Herpes immunization - on the thresh-old. J. Eur. Acad. Dermatol. Venerol. (1996) 7:120–128.
   Google Scholar
• Committee on issues and priorities for new vaccine de-velopment. Appendix I: prospects for immunizing against herpes simplex viruses 1 and 2. In: New Vaccine Development: Establishing Prioirities. National Academy Press, Washington DC, USA (1985):280–312.
   Google Scholar
• FLEMING DT, MCQUILLAN GM, ST.LOUIS ME: HerpesSimplex Virus type 2 in the United States, 1976 to 1994. New Engl. J. Med. (1997) 337(16):1105–1111.
   Google Scholar
• WHITLEY RJ: Herpes Simplex Viruses. In: Field Virology(Third Edition). Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Publishers, Philadelphia, USA (1996) :2297–2342.
   Google Scholar
• MANICKAN E, KAREM KL, ROUSE BT: DNA vaccines- amodern gimmick or a boon to vaccinology? Crit. Rev. Immunol. (1997) 17:139–154.
   Google Scholar
• MONTGOMERY DL, DONNELLY JJ, SHIVER JW, LIU MA,ULMER JB: Protein expression in vivo by injection of polynucleotides. Cum Opin. Biotechnol (1994) 5:505–510.
   PubMedGoogle Scholar
• ULMER JB, DONNELLY JJ, PARKER SE eta].: Heterologousprotection against influenza by injection of DNA en-coding a viral protein. Science 259:1745–1749.
   Google Scholar
• TANG DC, DEVIT M, JOHNSTON SA: Genetic immuniza-tion is a simple method for eliciting an immune re-sponse. Nature 356:152–154.
   Google Scholar
• COX GJM, ZAMB TJ, BABIUK LA: Bovine Herpes Virus. I.Immune responses in mice and cattle injected with plasmid DNA. j Viroi (1993) 67:5664.
   Google Scholar
• MANICKAN E, ROUSE RJD, YU Z, WIRE WS, ROUSE BT: Ge-netic immunisation against Herpes Simplex Virus: protection is mediated by CD4+ T-lymphocytes. JIm-munol (1995) 155:259–265.
   PubMed Web of Science ®Google Scholar
• BOURNE N, STANBERRY LR, BERNSTEIN DI, LEW D: DNAimmunization against experimental genital Herpes Simplex Virus infection. J Infect. Dis. (1996) 173:800–807.
   PubMed Web of Science ®Google Scholar
• MANICKAN E, YU Z, ROUSE RJD, WIRE WS, ROUSE BT: In- duction of protective immunity against Herpes Sim-plex Virus with DNA encoding the immediate early protein ICP 27. Viral Immunol. (1995) 8(2):53–61.
   PubMed Web of Science ®Google Scholar
• MANICKAN E, FRANCOTTE M, KUKLIN NA eta].: Vaccina-tion with recombinant vaccinia viruses expressing ICP 27 induces protective immunity against Herpes Sim-plex Virus through CD4+ The T-cells. J Viroi (1995) 69:4711–4718.
   Google Scholar
• MANICKAN E, YU Z, ROUSE BT: DNA immunization ofneonates induces immunity despite the presence of maternal antibody. j an. Invest (1997) 100:1–5.
   PubMedGoogle Scholar
• Herpes Simplex Virus - pathogenesis, immunobiology and control. In: Current Topics in Microbiology.and Immu-nology. Rouse BT (Ed.), Springer-Verlag, Berlin Heidelberg (1992).
   Google Scholar
• MCCLEMENTS WL, ARMSTRONG ME, KEYS RD, LIU MA:Immunization with DNA vaccines encoding glycopro-tein B, alone or in combination, induces protective im-munity in animal model of Herpes Simplex Virus-2 disease. Proc. Natl. Acad. Scs. (1996) 93(21):11414–11420.
   PubMed Web of Science ®Google Scholar
• KRIESEL JD, SPRUANCE SL, DAYNES RA, ARANEO BA: Nu-cleic acid vaccine encoding gD2 protects mice from Herpes Simplex Virus Type 2 disease./ Infect. Dis (1996) 173 (3):536–541.
   Google Scholar
• GHIASI H, CAI S, SLANINA S, NESBURN AB, WECHSLER SL:Vaccination of mice with HSV Type 1 glycoprotein D, DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. (1995) 28:147–157.
   PubMed Web of Science ®Google Scholar
• MESTER J, MILLIGAN GN, BERNSTEIN DI: The Immuno-biology of Herpes Simplex Virus, In Genital and Neonatal Herpes, Stanberry LR (Ed.), John Wiley and Sons. Ltd. (1996):49–91.
   Google Scholar
• KUKLIN NA, DAHESHIA M, KAREM K, MANICKAN E, ROUSE BT: Induction of mucosal immunity against Herpes Simplex Virus by DNA immunization. J. Virol (1997) 71 (4):3138–3145.
   PubMed Web of Science ®Google Scholar
• KUKLIN NA, DAHESHIA M, SANGJUN C, ROUSE BT: Onthe role of mucosal immunity in HSV infections. (Sub-mitted.)
   Google Scholar
• CONDON C, WATKINS SC, CELLUZZI CM, THOMPSON K,FALO LD, Jr.: DNA based immunization by in vivo trans-fection of dendritic cells. Nat. Med. (1996) 2(10):1122–1128.
   Google Scholar
• DOE B, SELBY M, BARNETT S, BAENZIGER J, WALKER CM: Induction of cytotoxic T-lymphocytes by im. immuni-zation with plasmid DNAis facilitated by bone marrow derived cells. Proc. Natl. Acad. Sci. USA. (1996) 93(16)8578–8583.
   Google Scholar
• FU TM, ULMER JB, CAULFIELD MJ eta].: Priming of cyto-toxic T-lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. (1997) 3 (6):362–371.
   Google Scholar
• ULMER JB, DECK RR, DEWITT CM, DONNHLY JI, LIU MA: Generation of WIC class I restricted cytotoxic T-lymphocytes by expression of a viral protein in mus-cle cells: antigen presentation by non-muscle cells. Im-munology (1996) 89 (1):59–67.
   Google Scholar
• ROUSE RJD, NAIR SK, LYDY SL, BOWEN JC, ROUSE BT: In-duction of in vitro primary cytotoxic T-lymphocytes responses with DNA encoding Herpes Simplex Virus proteins. J. Viroi (1994) 68:5685–5689.
   PubMed Web of Science ®Google Scholar
• NAIR SK, ROUSE RJD, BRUCE BD, ROUSE BT: Interaction between macrophages and dendritic cells involves a putative peptide chaperone. (Submitted.)
   Google Scholar
• ZAROZINSKI CC, FYNAN EF, SELIN LK, ROBINSON HL, WELSH RM: Protective CTL -dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. immunoi (1995) 154:4010–4017.
   PubMed Web of Science ®Google Scholar
• MANICKAN E, KANANGAT S, ROUSE RJD, YU Z, ROUSE BTR: Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukoc. Biol. (1997) 61:125–132.
   PubMed Web of Science ®Google Scholar
• XIANG Z, ERTL HCJ: Manipulation of the immune re-sponse to a plasmid encoded viral antigen by coinocu-lation with plasmid expressing cytokines. Immunity (1995) 2:129–135.
   PubMed Web of Science ®Google Scholar
• KIM JJ, AYYAVV00 V, BAGARAZZI ML eta].: In vivo engi-neering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogen. j immunoi (1997) 158 (2):816–826.
   Google Scholar
• KLAVINSKIS LS, GAO L, BARNFIELD C, LEHNER T, PARKER S: Mucosal immunization with DNA - liposome com-plex. Vaccine (1997) 15:818–820.
   PubMed Web of Science ®Google Scholar
• FOGERITE SG: Mucosal and systemic immunization us-ing cochleate and lip osome vaccine. j Liposome Res. (1996) 6:357–79.
   Google Scholar
• WANG B, UGEN KE, SRIKANTAN V et al.: Gene inocula-tion generates immune responses against immunode-ficiency virus Type 1. Proc. Natl. Acad. Sci. USA (1993) 90:4156–4163.
   PubMed Web of Science ®Google Scholar
• STREILEIN JW, DANA MR, KSANDER BR: Immunity caus-ing blindness: five different paths to herpes stromal keratitis. Immunol. Today (1997) 18(9):443–449.
   PubMedGoogle Scholar
• NIEMIALTOWSKI MG, ROUSE BT: Predominance of Th1 cells in ocular tissues during herpetic stromal kerati-tis. (1992) 149 (9):3035–3039.
   Google Scholar
• TUMPEY TM, ELNER VM, CHEN SH, OAKES JE, LAUSCH RN: Interleukin-10 treatment can suppress stromal keratitis induced by Herpes Simplex Virus Type 1. J Immunol. (1994) 153 (5):2258–2265.
   PubMed Web of Science ®Google Scholar
• BABU JS, KANANGAT S, ROUSE BT: T-cell cytokine mRNA expression during the course of the immunopa-thological ocular disease herpetic stromal keratitis. Immunol (1995) 154:4822–4829.
   Web of Science ®Google Scholar
• DAHESHIA M, KUKLIN NA, KANANGAT sincerely, MAN-ICKAN E, ROUSE BT: Suppression of ongoing ocular in-flammatory disease by topical administration of plasmid DNA encoding IL-10. J. immunoi. (1997) 159:1945–1952.
   PubMed Web of Science ®Google Scholar
• DAHESHIA M, KUKLIN NA, SANGJUN C, ROUSE BT: In vivo immunomodulation of herpes infections by cyto-kine gene therapy. (Submitted.)
   Google Scholar
• KASAMA T, STRIETER RM, LUKACS NW, BURDICK MD, KUNKEL SL: Regulation of neutrophil-derived che-mokine expression by IL-10. J. immuna (1994) 152:3559–3569.
   PubMed Web of Science ®Google Scholar
• SANGJUN C, DAHESHIA M, KUKLIN NA, ROUSE BT: Pro-phylactic administration of IL-4 DNA ameliorates her-petic stromal keratitis. (Submitted.)
   Google Scholar
• MANICKAN E, DAHESHIA M, KUKLIN NA, SANGJUN C, ROUSE BT: Suppression of DTH responses by IL-10 DNA administration. (Submitted.)
   Google Scholar
• MOR G, YAMSHCHIKOV M, SEDEGAH M eta].: Induction of neonatal tolerance by plasmid DNA vaccination. J. Clin. Invest. (1996) 12:2700–2705.
   Google Scholar